Basic Information
Rivia is an intelligent technology enterprise focused on the clinical research field, with a core focus on building a data analysis engine that drives clinical trial intelligence. Leveraging AI technology, the company integrates fragmented clinical trial data from the biopharmaceutical industry into a unified intelligent analysis layer. It has developed three core product modules: Rivia Core, Rivia Detect, and Rivia Spark, which enable standardized integration of clinical trial data, intelligent quality detection, visual analysis, and natural language interactive queries. These products also provide real-time, actionable data analysis insights for medical scientific research, safety monitoring, clinical operations, and executive decision-making scenarios. Its products are deployed efficiently, capable of going live in as little as 20 days. Rivia has served multiple global biopharmaceutical companies such as Enyo Pharma, Omeicos Therapeutics, and Scancell, helping them streamline clinical trial data processing, enhance decision-making efficiency, reduce operational costs, and empower intelligent management throughout the entire clinical trial process.
Rivia
Zurich,Zurich,Switzerland
unclear
January 01, 2022
info@rivia.com

